Latest filing published 11 Aug 2017 for Regeneron Pharmaceuticals, INC., €85k.
Filing timeline
BuySaleInsider track record
Robert J. Terifay: trading record in brief
This profile gathers the share dealings of Robert J. Terifay in Regeneron Pharmaceuticals, Inc. Between 14 February 2011 and 10 August 2017, the trades on record add up to 107 filings.
No open-market purchase appears, only 49 sales worth €44.2M. Besides market trades, the filings include 32 share grants and 26 option exercises. Since January 2017: no purchases and 1 sale on the market.
On 11 August 2017 came the latest disclosure, an option exercise for €85k in Regeneron Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert J. Terifay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,921 shares@ US$52.030.4% of flowCommon StockSEC:0001708138-17-000013:0
- 48,750 shares@ US$52.0310.0% of flowCommon StockSEC:0001708138-17-000007:0
- 5,411 shares@ US$468.6910.0% of flowCommon StockSEC:0001708138-17-000007:1
- 22,192 shares@ US$468.6940.8% of flowCommon StockSEC:0001708138-17-000007:2
- 21,147 shares@ US$468.1938.9% of flowCommon StockSEC:0001708138-17-000007:3
- 3,264 shares@ US$30.63Common StockSEC:0001237899-15-000045:0
- 29,236 shares@ US$30.63Common StockSEC:0001237899-15-000045:1
- 1,521 shares@ US$588.64Common StockSEC:0001237899-15-000045:2
- 14,292 shares@ US$588.64Common StockSEC:0001237899-15-000045:3
- 2,007 shares@ US$585.22Common StockSEC:0001237899-15-000045:4
- 2,482 shares@ US$587.35Common StockSEC:0001237899-15-000045:5
- 2,126 shares@ US$588.55Common StockSEC:0001237899-15-000045:6
- 2,542 shares@ US$589.76Common StockSEC:0001237899-15-000045:7
- 2,486 shares@ US$590.57Common StockSEC:0001237899-15-000045:8
- 957 shares@ US$591.75Common StockSEC:0001237899-15-000045:9
- 23 shares@ US$592.40Common StockSEC:0001237899-15-000045:10
- 800 shares@ US$593.66Common StockSEC:0001237899-15-000045:11
- 24,375 shares@ US$30.63Common StockSEC:0001237899-15-000025:0
- 1,679 shares@ US$444.46Common StockSEC:0001237899-15-000025:1
- 11,703 shares@ US$444.46Common StockSEC:0001237899-15-000025:2
- 2,600 shares@ US$448.01Common StockSEC:0001237899-15-000025:3
- 300 shares@ US$448.87Common StockSEC:0001237899-15-000025:4
- 2,093 shares@ US$450.18Common StockSEC:0001237899-15-000025:5
- 700 shares@ US$450.95Common StockSEC:0001237899-15-000025:6
- 3,200 shares@ US$452.61Common StockSEC:0001237899-15-000025:7
25 of 106 declarations
